In the study assessing intensified surveillance (i.e., frequent CEA measurements), colorectal cancer survivors found frequent blood tests more stressful, less reassuring, and more inconvenient.14 However, this anxiety subsided over time, suggesting adaptation to the intervention. The gene discussed is CEACAM5; the disease is colorectal cancer.